目的观察了解吉西他滨单药治疗老年晚期非小细胞肺癌(NSCLC)的临床疗效和毒性反应。
Objective: to evaluate the clinical effect and toxicity of gemcitabine monotherapy in the treatment of elder advanced non-small cell lung cancer (NSCLC).
目的：评价国产药与进口药盐酸吉西他滨治疗非小细胞肺癌(NSCLC)的疗效、安全性及不良反应。
Objective: To evaluate the curative effect, safety and adverse reaction of domestic and imported gemcitabine hydrochloride in non-small cell lung cancer (NSCLC).
目的评价长春瑞滨（NVB）与顺铂（DDP）及吉西他滨（GEM）与顺铂联合化疗治疗晚期非小细胞癌（NSCLC）的疗效及毒副作用。
Objective To evaluate the toxicity and clinical activity of navelbine(NVB) plus cisplation(DDP) and gemcitabine(GEM) plus cisplation in the treatment of advanced non-small cell lung cancer(NSCLC).
目的观察吉西他滨联合伯尔定治疗晚期非小细胞肺癌的疗效及毒副作用。
Objective to observe the efficacy and toxicity of gemcitabine plus Carboplatin in the treatment of advanced non-small-cell lung cancer (NSCLC).
目的观察不同剂量、用法的吉西他滨联合伯尔定治疗晚期非小细胞肺癌的疗效和不良反应。
Objective to observe the efficacy and toxicity of gemcitabine of different dosages and methods plus carboplatin in patients with advanced non-small-cell lung cancer (NSCLC).
吉西他滨是近年来治疗晚期非小细胞肺癌的有效新药。
Gemcitabine is a new active drug in the treatment of advanced non small cell lung cancer (NSCLC).
吉西他滨是近年来治疗晚期非小细胞肺癌的有效新药。
Gemcitabine is a new active drug in the treatment of advanced non small cell lung cancer (NSCLC).
应用推荐